Trial
NCT04890353
Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Xuanwu Hospital, Beijing
Collaborators
—
Condition
Acute Ischemic Stroke
Intervention
Dimethyl fumarate
Why stopped
The interim analysis of another associated study is not very effective
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-25